In the last 30 days, fiscal earnings estimates have been increased by most of the analysts, driven by its diversified portfolio that provides a hard-to-replicate competitive advantage over its peers. The healthcare sector is relatively immune to the downturn in the economy, and provides a steady source of income that insulates the company from short-term market volatility.
Fiscal earnings estimates have moved up for HCP in the last 30 days, indicating that the analysts are bullish about its long-term performance. Our long-term Outperform recommendation on the stock indicates that it would perform well above the broader market.
HCP INC (HCP): Free Stock Analysis Report
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.